News and Press Releases
Toxys Reports Positive Results from the OECD Ring Trial Validation of ToxTracker in a Peer-Reviewed Article
9 April 2024 -- Oegstgeest, The Netherlands -- Today Toxys announces the peer-reviewed publication of the positive results from an international interlaboratory validation of ToxTracker. ToxTracker is an in vitro...
Category: Biotechnology, Pharmaceutical
Posted: April 9, 2024
Veklury (remdesivir) recommended by NICE for treatment of COVID-19 in vulnerable adults and children
Remdesivir is the first antiviral treatment recommended by NICE to treat eligible children, including those with a high risk of serious illness from COVID-19 This decision secures long-term access to...
Category: Pharmaceutical
Posted: April 9, 2024
G.ST Antivirals reports start of Phase 2 trial and announces appointment of Ronald Bruce Turner as new Chief Medical Officer
Phase 2 clinical trial started, first subject in on 2 April 2024 New CMO Ronald Bruce Turner MD, distinguished expert in the clinical research of rhinoviruses, to oversee trial and...
Category: Biotechnology, Clinical Trials
Posted: April 9, 2024
Bespak confirms completion of inhaled and nasal drug delivery business separation from Recipharm to focus on the transition to low GWP pMDIs
Spin-out unites three sites to create a leading global CDMO as further significant investments announced at Holmes Chapel site 2 April 2024 – Holmes Chapel, UK, and Stockholm, Sweden –...
Category: Drug Delivery, Manufacturing and Packing
Posted: April 9, 2024
Celonic Launches New GS-CHOvolution Cell Line Expression System
GS-CHOvolution is based on Revvity’s CHOSOURCE expression platform and TnT transposon technology 8 April 2024 -- Basel, Switzerland -- Celonic has signed a commercial license agreement with Revvity for its CHOSOURCE...
Category: BioManufacturing
Posted: April 8, 2024
Gilead extends partnership with NHS England to eliminate hepatitis C by 2025
Since the commencement of the Strategic Procurement agreement in 2019, Gilead has worked in partnership with NHS England, non-profit organisations, and industry to help treat and cure over 84,000 people...
Category: Other, Pharmaceutical
Posted: April 8, 2024
GSK’s Jemperli▼ (dostarlimab) is accepted for use within NHS Scotland, in line with its licence, in eligible endometrial cancer patients in first line setting
Clinicians in Scotland will now be able to use dostarlimab in combination with platinum-containing chemotherapy for the treatment of adult patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced...
Category: Pharmaceutical
Posted: April 8, 2024
Scottish Medicines Consortium (SMC) accepts Camzyos▼(mavacamten) for use on the NHS as an adjunct treatment option for adults with symptomatic obstructive hypertrophic cardiomyopathy
Mavacamten has been accepted for use within NHS Scotland for the treatment of symptomatic(New York Heart Association, NYHA, class II to III) obstructive hypertrophic cardiomyopathy(HCM) in adult patients. HCM is...
Category: Pharmaceutical
Posted: April 8, 2024
ARC Uxbridge Sanderson Road New Denham Denham Buckinghamshire UB8 1DH
ETIHAD CARGO EXPANDS US CAPACITY WITH INAUGURAL BOSTON FLIGHT
Etihad Cargo has launched a fourth gateway destination in the US, operating its inaugural flight to Boston on 31 March. The carrier will operate four flights per week to Boston,...
Category: Logistics
Posted: April 8, 2024
Andaman7 Launches AI Supercharged Personal Health Record v5
New advanced AI simplification, summarisation and translation features empower patients and improve communication with healthcare providers and researchers 4 April 2024 -- Liège, Belgium -- Andaman7, the free app transforming...
Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: April 4, 2024
Cherwell demonstrates strong distributor support at LabDays 2024
Prepared microbiological media product insight to be shared on Dorte Egelund’s stand by Cherwell experts at LabDays Stockholm 2024 4 April 2024 -- Bicester, UK -- Cherwell, cleanroom microbiology solutions...
Category: Biotechnology
Posted: April 4, 2024
Launton Business Centre Murdock Rd, Bicester OX26 4XB
Grifols Procleix ArboPlex Assay Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening
Grifols’ in vitro nucleic acid test detects four types of arboviruses, helping mitigate the risk of transfusion-transmitted infections Arboviruses are a growing emerging threat, with changes in climate and increasing...
Category: Biotechnology, Pharmaceutical
Posted: April 4, 2024
Avinguda de la Generalitat, 152 Parc empresarial Can Sant Joan 08174 Sant Cugat del Vallès, Barcelona SPAIN
University of Liverpool to Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical Study
The UK’s Medical Research Council is funding a 10-patient phase 1 study to deliver rapid personalised treatment for lung cancer patients 3 April 2024 -- Hampton, UK -- Touchlight, a...
Category: Biotechnology, Clinical Trials
Posted: April 3, 2024
First Study Using Biomimetic AI Digital Twins And Multiomics in Genetics Research
Paper on the ground-breaking research by Genzeva, LumaGene, RYLTI, Brigham & Women’s Hospital of Harvard University, and QIAGEN Digital Insights was published this week in the Journal of Molecular Diagnostics 3 April...
Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: April 3, 2024
dsm-firmenich and OMG Pharma form strategic collaboration to advance first-of-a-kind CBD-based drugs for insomnia
3 April 2024 – Kaiseraugst, Switzerland; Heerlen, Netherlands – dsm-firmenich, has announced a new strategic collaboration with Oz Medicann Group (OMG) Pharma – an Australian-based biotech innovator in the cannabinoid...
Category: Biotechnology, Drug Delivery
Posted: April 3, 2024
